Postoperative recurrence analysis of breast cancer patients based on clinical serum markers using discriminant methods
Kidney and Neoplastic Disease: Overview with a Particular Interest to Interpretation of Cancer Biomarkers | SpringerLink
Colorimetric and photothermal dual-mode immunoassay for tumour marker detection based on a Ag2CO3@Ag nanocomposite - ScienceDirect
Colorimetric and photothermal dual-mode immunoassay for tumour marker detection based on a Ag2CO3@Ag nanocomposite - ScienceDirect
Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery
H&E and immunohistochemical stains for PR, ER, Vim and CEA identified... | Download Scientific Diagram
Native Soluble Carcinoembryonic Antigen Is Not Involved in the Impaired Activity of CD56 dim Natural Killer Cells in Malignant P
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecologic
Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: Evaluation of CEA-based cancer vaccines - ScienceDirect
Diagnostic Value of CYFRA 21–1 Tumor Marker and CEA in Pleural ...
PDF) Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers
Original Article Clinical characteristics and serum levels of tumor markers of connective tissue disease-associated interstiti
Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas – A Pilot Study | Anticancer Research
Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: Evaluation of CEA-based cancer vaccines - ScienceDirect
Table I from Tumor markers in pleural effusions. | Semantic Scholar
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecologic
A label-free electrochemical immunosensor for carcinoembryonic antigen detection on a graphene platform doped with poly(3,4-ethy
PDF) Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecologic
A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect
PDF) Cyotokines and surrogate markers in HIV-related opportunistic malignancies | Giovanni Penco - Academia.edu
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecologic
COVER MANUAL BOOK IMUN LW | Immunology | Medical Specialties
PDF) Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecologic
Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram
